Antisense oligonucleotides directed against connective tissue growth factor and uses thereof

Details for Australian Patent Application No. 2009275387 (hide)

International Classifications

Event Publications

11 March 2010 Application Open to Public Inspection

Published as AU-B-2009275387

11 March 2010 PCT application entered the National Phase

1 April 2010 Alteration of Name

The name of the applicant has been altered to Isis Pharmaceuticals, Inc.; Excaliard Pharmaceuticals, Inc.

8 July 2010 Application Accepted

Published as AU-B-2009275387

4 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.